13,168 Shares in Centene Corporation $CNC Acquired by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC purchased a new position in Centene Corporation (NYSE:CNC) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 13,168 shares of the company’s stock, valued at approximately $818,000.

Several other large investors have also added to or reduced their stakes in CNC. Krilogy Financial LLC boosted its stake in shares of Centene by 9.4% during the 3rd quarter. Krilogy Financial LLC now owns 74,818 shares of the company’s stock valued at $4,648,000 after purchasing an additional 6,435 shares in the last quarter. Clay Northam Wealth Management LLC bought a new position in Centene in the third quarter worth about $125,000. Forvis Mazars Wealth Advisors LLC bought a new position in Centene in the third quarter worth about $295,000. Accel Wealth Management bought a new position in Centene in the third quarter worth about $657,000. Finally, Lincoln Capital Corp lifted its holdings in Centene by 31.6% in the third quarter. Lincoln Capital Corp now owns 4,410 shares of the company’s stock worth $274,000 after buying an additional 1,059 shares during the period. Institutional investors own 93.63% of the company’s stock.

Centene Trading Up 0.6%

NYSE:CNC opened at $70.62 on Friday. The firm has a market capitalization of $34.88 billion, a P/E ratio of -6.76, a PEG ratio of 0.44 and a beta of 1.13. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. Centene Corporation has a one year low of $31.63 and a one year high of $71.01. The company’s 50-day simple moving average is $65.34 and its 200 day simple moving average is $59.60.

Centene (NYSE:CNC) last announced its earnings results on Monday, July 27th. The company reported $2.51 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $1.42. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The business had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. During the same quarter last year, the firm earned ($0.16) earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. As a group, analysts forecast that Centene Corporation will post 4.89 EPS for the current fiscal year.

Insider Buying and Selling at Centene

In related news, General Counsel Christopher Koster sold 56,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total value of $3,779,850.00. Following the sale, the general counsel owned 248,854 shares in the company, valued at $16,648,332.60. This represents a 18.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.37% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

CNC has been the topic of several research reports. Wells Fargo & Company set a $69.00 price objective on Centene and gave the company an “equal weight” rating in a research report on Monday, July 13th. Sanford C. Bernstein reissued an “outperform” rating and issued a $79.00 target price (up from $68.00) on shares of Centene in a research report on Monday, August 3rd. HC Wainwright restated a “buy” rating on shares of Centene in a research note on Friday, September 11th. Weiss Ratings upgraded Centene from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. Finally, Barclays restated an “overweight” rating and set a $80.00 price target (up from $75.00) on shares of Centene in a research report on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Centene currently has an average rating of “Hold” and an average target price of $70.05.

Centene Profile

Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides health insurance and related services, primarily through government-sponsored programs. Its offerings include Medicaid plans, Medicare products, health plans sold through the Affordable Care Act marketplace, and services for military families through government-sponsored healthcare programs.

The company also provides pharmacy, behavioral health, specialty healthcare, care management and administrative services through various subsidiaries and partner organizations.